Recent studies suggest that dysregulated signaling pathways involving progranulin and angiogenesis may contribute to the pathogenesis of ECCL as it is involved in cutaneous and systemic manifestations. This evidence concerns the gene GRN and encephalocraniocutaneous lipomatosis.